As the science stands, the vast majority of the roughly eight million people in South Africa living with HIV will have to get ...

The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of HIV research findings at the International ...

Researchers remain hopeful that they're heading in the right direction to finding a cure for HIV, the virus that causes AIDS. Right now, it’s still out of reach. But the unusual cases of four ...

A virologist at the University of Nebraska-Lincoln, Qingsheng Li, was awarded $3.5 million to advance his work on a vaccine ...

Proof-of-Concept Study to Find Functional Cure for HIV July 24, 2024 — Researchers conducted a breakthrough proof-of-concept study that found an HIV-like virus particle that could cease the need ...

Nebraska Aids Project is celebrating 40 years with its annual Night of a Thousand Stars fundraiser. The gala will contribute ...

While a cure sounds like great news ... driven by slower growth in the HIV franchise. The company posted adjusted earnings of ...

SYNC, its first homegrown CAR-T therapy, one of the first to show promise in treating certain types of brain cancers. This ...

Identifying best practices that will prevent HCV transmission in MSM with HIV is needed to reduce HCV reinfection rates in ...

Professor Thumbi Ndung’u from UKZN has been elected to the US National Academy of Medicine, recognising his significant contributions to HIV research ...

Immunocore reports third quarter financial results and provides a business updateKIMMTRAK® (tebentafusp-tebn) net revenues of $80.2 million in 3Q ...